Diagnostic Performance and Safety of Pegsitacianine for the Detection of Cancer in Patients With Unknown Primary Head and Neck Cancer
Conditions: Head and Neck Cancer; Unknown Primary Cancer; Head and Neck Squamous Cell Carcinoma Intervention: Biological: Pegsitacianine Sponsor: University of Texas Southwestern Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Carcinoma of Unknown Primary | Head and Neck Cancer | Research